histopathologic evaluation of biopsies of uveal tumors in comparison to clinical diagnosis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031187

Enrollment

Registered

2023-06-05

Start date

2023-06-05

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C69

Interventions

Group 1: Comparison of clinical diagnosis and histopathologic diagnosis in patients who underwent a transretinal biopsy of an uveal tumor between 2012 and 2022. Retrospective data extraction and analy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients who underwent a transretinal biopsy of a tumor

Exclusion criteria

Exclusion criteria: previous biopsies of the same tumor

Design outcomes

Primary

Measure	Time frame
analysis of the correlation of clinical and histoptahological diagnosis in regard to tumor dignity by calculation of sensitivity and specificity (gold standard: histopathologic diagnosis), using the retrospectively extracted parameters for clinical and histopathologic diagnosis	—

Secondary

Measure	Time frame
description of histopathologic evaluations of tumor biopsies	—

Countries

Germany

Contacts

Public ContactChristoph Ehlken

Klinik für Ophthalmologie, UKSH Kiel

christoph.ehlken@uksh.de+4943150024231

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026